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Tissue engineering techniques using novel scaﬀold materials oﬀer potential alternatives for managing tendon disorders. Tissue
engineering strategies to improve tendon repair healing include the use of scaﬀolds, growth factors, cell seeding, or a combination
of these approaches. Scaﬀolds have been the most common strategy investigated to date. Available scaﬀolds for tendon repair
include both biological scaﬀolds, obtained from mammalian tissues, and synthetic scaﬀolds, manufactured from chemical
compounds. Preliminary studies support the idea that scaﬀolds can provide an alternative for tendon augmentation with an
enormoustherapeuticpotential.However,availabledataarelackingtoallowdeﬁnitiveconclusionontheuseofscaﬀoldsfortendon
augmentation. We review the current basic science and clinical understanding in the ﬁeld of scaﬀolds and tissue engineering for
tendon repair.
1.Introduction
Tissue engineering techniques using novel scaﬀold materials
oﬀer potential alternatives for managing tendon disorders
[1]. Tissue engineering strategies to improve tendon repair
healing include the use of scaﬀo l d s ,g r o w t hf a c t o r s ,c e l l
seeding, or a combination of these approaches [1]. Scaﬀolds
havebeenthemostcommonstrategyinvestigatedtodate[1].
The rationale for using a scaﬀold device for tendon repair
may include mechanical augmentation, improving the rate
and quality of biologic healing, or both [2]. Scaﬀolds with
robust mechanical and suture retention properties, applied
in a surgically appropriate manner, may have the ability
to “oﬀ-load” the repair at time zero and for some period
of postoperative healing, depending on the rate and extent
of scaﬀold remodeling. Despite the growing clinical use
of scaﬀold devices for tendon repair, there are numerous
questions related to their indication, surgical application,
safety, mechanism of action, and eﬃcacy that remain to be
clariﬁed or addressed [1].
The use of scaﬀolds alone in ﬂexor tendons has not been
highly studied, but they have been combined with tenocytes
in an eﬀort to engineer an autologous tendon graft [3, 4].
However, the use of scaﬀolds in ﬂexor tendon repairs may
have a detrimental eﬀect on tendon gliding, due to their size,
and the lack of space within a repaired synovial sheath.
Scaﬀolds for both the Achilles tendon and the rotator
cuﬀ have been investigated both as structural supports and
as delivery systems for other tissue engineering modalities.
Available scaﬀolds for tendon repair include both biological
and synthetic scaﬀolds [5]. In this paper we review the cur-
rent basic science and clinical understanding of scaﬀolds and
tissue engineering for tendon repair. We underline beneﬁts
and limitations of the available scaﬀolds for augmentation of
tendon disorders and discuss the implications of these data
on future directions for the use of these scaﬀolds in tendon
repair procedures.
2.Biological Scaffolds
Biological scaﬀolds are obtained from mammalian (human,
porcine, bovine, and equine) tissues [6]. To remove any
noncollagen components, thus, minimizing the risk of host2 Stem Cells International
rejection while retaining its natural collagen structure and
mechanical properties, small intestine submucosa (SIS), der-
mis, and pericardium are processed through cascade steps,
including general cleaning, removal of lipids or fat deposits,
disruption of cellular and DNA materials, crosslinking, and
sterilization [6] .T h eﬁ n a ls c a ﬀolds are composed mainly
of naturally occurring collagen ﬁbres, predominantly type
I collagen, and several of them have a surface chemistry
and native structure that is bioactive and promotes cellular
proliferation and tissue ingrowth [6].
The Restore graft (Depuy, Warsaw, IN) is a circular im-
plant consisting of 10 not crosslinked layers of porcine small
intestinal submucosa (SIS). It is more than 90% collagen
with approximately 5–10% lipids and a small amount of
carbohydrate [7, 8]. Iannotti et al. [9] tried to determine the
eﬀectiveness of porcine SIS to augment the repair of rotator
cuﬀ. They randomized 30 shoulders with a chronic two-
tendon rotator cuﬀ tear (9 with a large tear and 21 with a
massive tear of rotator cuﬀ) that was completely repairable
with open surgery to be managed with either augmentation
withporcineSISornoaugmentation.Therotatorcuﬀhealed
in4ofthe15shouldersintheaugmentationgroupcompared
with 9 of the 15 in the control group. The authors concluded
that augmentation of the surgical repair of large and massive
chronic rotator cuﬀ tears with porcine SIS did not improve
the rate of tendon healing or the clinical outcome scores. On
thebasisoftheirinvestigation,theydonotrecommendusing
porcine SIS to augment repairs of massive chronic rotator
cuﬀ tears performed with the surgical and postoperative
procedures described in this study. Metcalf et al. [10]
conducted a 2-year followup of 12 patients who underwent
arthroscopic repair of massive chronic rotator cuﬀ tears
using Restore SIS as an augmentation device. Postoperative
magnetic resonance imaging (MRI) scans showed signiﬁcant
thickening of the cuﬀ tendon with the incorporation of the
SISgraftin11patients.In1of12patients,clinicalfailurewas
observed within 12 weeks with complete resorption of the
graft. There was no evidence of local or systemic rejection or
infection in any patient. The mean postoperative University
of California, Los Angeles, (UCLA) score was 19.9 on a scale
of 35, a signiﬁcant improvement over the preoperative score
of 9.9, but the shoulder function remained far below normal
in these patients. This study demonstrated improved post-
operative outcomes for patients managed with the Restore
graft augmentation compared with their preoperative condi-
tion. However, the lack of a control group makes it diﬃcult
to conclude that the functional improvements in the study
were the result of SIS augmentation. Sclamberg et al. [11]
evaluated clinical and MRI at 6 months in 11 patients
undergoing open repair of large or massive rotator cuﬀ tears
augmented with Restore. MRI showed a retear in 10 of 11
patients. Zheng et al. [12]p e r f o r m e das t u d yt oe v a l u a t et h e
safety and eﬃcacy of the Restore SIS membrane. The Restore
orthobiologic implant was examined by histology and
the nested PCR technique using porcine immunoreceptor
DAP12 gene to examine if SIS membrane contained porcine
cells or DNA, respectively. The material was also implanted
into mice and rabbits for the evaluation of biological
reaction and inﬂammatory response. Restore SIS was found
to contain multiple layers of porcine cells. Chloroacetate
esterase staining showed that some of these cells were mast
cells. Nested PCR of the DAP12 gene demonstrated that
Restore SIS contained porcine DNA material. Subcutaneous
implantation of Restore SIS membrane in mice, and in
rabbits for rotator cuﬀ tendon repair, showed that the mem-
brane caused an inﬂammatory reaction characterized by
massive lymphocyte inﬁltration. The authors concluded that
Restore SIS is not an acellular collagenous matrix, and con-
tains porcine DNA, contradicting the current view that Re-
store SIS is a cell-free biomaterial and that no inﬂammatory
response is elicited by its implantation. Walton et al.
[13] compared a group of patients who had undergone
rotator cuﬀ repair with xenograft augmentation with a
group repaired without augmentation. Four patients in the
xenograft group showed a severe postoperative reaction
requiring surgical treatment. Two years postoperatively, MRI
documented retears in 6 of the 10 tendons repaired with a
xenograft and in 7 of the 12 nonaugmented tendons; the
patients with a xenograft also had less strength than the
controls and had more impingement in external rotation,
a slower rate of resolution of pain during activities, more
diﬃculty with hand-behind-the-back activities, and a lower
rate sports participation.
The Zimmer Collagen Repair Patch (Tissue Science Lab-
oratories, Covington, Ga, USA, licensed to Zimmer) is a
single layer porcine skin xenograft. It is an acellular cross-
linked collagen sheet of crosslinked porcine dermis. Soler et
al. [14] used Zimmer Collagen Patch as a bridging device to
repair massive rotator cuﬀ tears. After a good postoperative
period, between 3 and 6 months, the graft began to fail,
and the patients showed signs and symptoms of retear, with
also signs of inﬂammation. MRI scans showed inﬂamma-
tory changes, resorption of the graft, ﬂuid pooling in the
subdeltoid bursa, and loss of continuity of the remaining
graft material. Histology of the debris revealed necrotic
ﬁbrinousmaterialonabackgroundofchronicinﬂammation.
Badhe et al. [15] prospectively evaluated 10 patients with
extensive rotator cuﬀ tear treated with Zimmer Collagen
Patch (Permacol). All patients experienced signiﬁcant pain
relief and improvement in abduction power and range of
motion. Ultrasound imaging at the ﬁnal followup identiﬁed
intact grafts in eight and disrupted grafts in two patients.
GraftJacket (Wright Medical Technology, Inc.) is a com-
mercially available acellular dermal matrix obtained from
tissue bank human skin, composed of collagen types I, III,
IV, and VII, elastin, chondroitin sulfate, proteoglycans, and
ﬁbr oblastgr o wthfact or .I thasanintactbasementmembrane
complex and preserved vascular channels to allow rapid
inﬁltration of ﬁbroblasts and vascular tissue, with minimal
host inﬂammatory response [3, 8, 13]. Barber et al. [16]
compared the failure mode of supraspinatus tendon repair
with and without GraftJacket augmentation in a human
cadaveric model. No signiﬁcant displacement occurred dur-
ing the cyclic phase, and no anchors failed. During the
destructive testing phase, the mean load-to-failure strength
of the control construct was 273 + 116N. The load-to-
failure strength of the supraspinatus tendon augmented with
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diﬀerent mechanisms: tendon-suture interface failure (8/10
nonaugmented repairs and 6/10 augmented repairs) and
suture breakage (2/10 non-augmented repairs and 4/10
augmented repairs). Bond et al. [17] treated 16 patients with
massive rotator cuﬀ tears with arthroscopic implantation of
a GraftJacket allograft. At a mean followup of 26.7 months,
15 of 16 patients were satisﬁed with the procedure. The
mean UCLA score increased from 18.4 preoperatively to 30.4
postoperatively. The mean pain score improved from 4.6
to 9.8 postoperatively. The mean constant score increased
from 53.8 to 84.0. Statistically signiﬁcant improvements
were noted in pain, forward ﬂexion, and external rotation
strength. MRI scans showed full incorporation of the graft
into the native tissue in 13 patients. Chronic Achilles tendon
rupture, repaired with GraftJacket, showed early return to
activity and good plantarﬂexion strength [18]. Two studies
[19, 20] evaluated GraftJacket as an augmentation device
in the Achilles tendon repair. In the ﬁrst study [19], nine
patients with chronic Achilles tendon ruptures were followed
up. There were no reruptures or recurrent pain at 20–30
months postoperatively, and the average return-to-activity
time was 15.2+1 .7 weeks. In the second study [20], 11
patients with acute tendon ruptures were followed up for 20
to 31 months. At 20 months, there were no reruptures or
recurrent pain; the average return-to-activity time was 11.8
+ 0.75 weeks. Signiﬁcant increase in strength and stiﬀness of
Achilles tendon repair augmented with GraftJacket was also
observed in a human cadaver model (12.99 + 5.34N/mm
versus 4.29 + 0.83N/mm of the control group) [21].
3. Synthetic Scaffolds
Because allograft materials may cause inﬂammatory
responses in the host, there is notable interest in developing
synthetic extracellular matrix (ECM) grafts for surgical
use. Synthetic ECMs may still serve as an adequate scaﬀold
for cellular and ﬁbrotic growth, while running a smaller
risk of provoking an inﬂammatory response than allograft
ECMs. Several animal studies have investigated the beneﬁt
of augmenting rotator cuﬀ repair with synthetic ECMs.
Yokoya et al. [22] used a polyglycolic acid (PGA) sheet
to augment rotator cuﬀ repairs of infraspinatus tendons in
Japanese white rabbits, showing histological improvement
in ﬁbrocartilage layering but only a slight improvement
in tensile strength when compared to control tendons
augmented with another slowly absorbing synthetic material
[22]. In a similar study, Funakoshi et al. [23] demonstrated
increased ﬁbroblast presence and collagen formation when
synthetic ECM was surgically applied to rotator cuﬀ tears.
In this experiment, a 10-mm surgical defect was created
at the humeral insertion of the infraspinatus tendon in 21
Japanese white rabbits. In one shoulder, the 10-mm defect
was covered with chitin, a biodegradable polymer, sutured
into the bone trough, and attached to the free end of the
infraspinatus tendon. The contralateral shoulder was left
untreated as a control. Throughout the experiment, tendon-
to-bone junctions covered with chitin fabric demonstrated
greater cell number, better collagen ﬁber alignment, and
greater mechanical strength than the tendon-to-bone junc-
t i o n sl e f tf r e ea sc o n t r o l[ 23]. In another study, MacGillivray
et al. [24] used polylactic acid patches in goats, showing
no observable diﬀerence between the treated and control
groups [24]. A similar experiment, using a woven poly-L-
lactide device, was performed by Derwin et al. [25]i na
dog model. The superior 2.3 of each infraspinatus tendon
was removed from the rotator cuﬀ and then repaired in
both shoulders. In one shoulder, a woven poly-L-lactide
device was placed over the repair. In the other shoulder, the
repair was left unaugmented. The augmented rotator cuﬀ
repair resulted in fewer tendon retractions, greater strength,
and increased stiﬀness when compared to the contralateral
untreated rotator cuﬀ repairs. A recent study demonstrates
that the application of the X-Repair device signiﬁcantly
increased the yield load and ultimate load of rotator cuﬀ
repairs in a human cadaveric model and altered the failure
mode but did not aﬀect initial repair stiﬀness [26].
4. TissueEngineeringwithMesenchymal
Stem Cells (MSCs)
Technological advances in biology and engineering have
resulted in marked improvements in the design and man-
ufacture of tissue-engineered substitutes that can modify
and maintain living tissue [27, 28]. Tissue engineering is
an emerging ﬁeld made up of the combination of scaﬀold,
cell and stimulation or their stand-alone application [29,
30]. MSCs are capable of diﬀerentiating into a variety of
specialized mesenchymal tissues including bone, tendon,
cartilage, muscle, ligament, fat, and marrow stroma [29, 30].
Tissue engineering can be divided into two subtypes: the
in vivo approach and the ex vivo, de novo one [27, 28].
The in vivo approach permits the self-regeneration of small
tissue lesions. The ex vivo, de novo approach is designed
to produce functional tissue that can be implanted in the
body [31]. Tissue engineering is a multidisciplinary ﬁeld
founded on three fundamental principles: (I) the use of
healthy multipotent cells that are nonimmunogenic, easy to
isolate, and highly responsive to distinct environmental cues,
(II) the development of carrier scaﬀolds that provide short-
termmechanicalstabilityofthetransplantandatemplatefor
spatial growth of the regenerate tissue, and (III) the delivery
of growth factors that drive the process of cell diﬀerentiation
and maturation [27, 28]. MSCs can be applied directly to the
site of injury or can be delivered on a suitable carrier matrix,
which functions as a scaﬀold while tissue repair takes place
[32].
The ideal scaﬀold for tendon engineering would possess
the basic structure of the tendon, native extracellular matrix,
and capability of cell seeding [33]. Decellularized multilayer
tendon slices were seeded with BMSC, harvesting BMSC
and infraspinatus tendons from dogs. Histology showed the
alignment of the seeded cells between the collagen ﬁbers of
the tendon slices. qRT-PCR analysis showed higher teno-
modulin and MMP13 expression and lower collagen type
I expression in the composite than in the BMSC before
seeding, suggesting that BMSC might express a tendon4 Stem Cells International
phenotype in this environment [33]. Delivering MSC-
contracted, organized collagen implants applied to large
tendon defects can signiﬁcantly improve the biomechanics,
structure, and probably the function of the tendon after
injury [34]. A tissue prosthesis made up of cultured, au-
tologous, marrow-derived MSCs suspended in a collagen
gel delivery vehicle and contracted onto a pretensioned su-
ture was implanted into a 1-cm-long gap defect in a rabbit
Achilles tendon [34]. Load-related structural and material
properties evaluated 4, 8, and 12 weeks later were greater
than in the control repairs, which contained suture alone
with natural cell recruitment. Furthermore, the treated tis-
sue showed a signiﬁcantly larger cross-sectional area, and
their collagen ﬁbers appeared to be better aligned than
those in the controls. The use of MSCs to enhance allograft
osteointegration is a novel method oﬀering the potential
of more physiologic and earlier healing [35]. MSCs derived
from synovium have a higher proliferation and diﬀeren-
tiation potential than the other MSCs. Their potential to
accelerate the early remodelling of tendon-bone healing
histologically by producing more collagen ﬁbers at 1 week
and forming more oblique collagen ﬁbers connecting the
bone to tendon resembling Sharpey’s ﬁbers at 2 weeks has
been shown [36]. Moreover, MSCs do not interfere with
tendon-bone healing at 4 weeks [36]. MSCs have been in-
vestigated in the management of tendinopathy. MSCs and
IGF-I genes enhanced MSCs (AdIGF-MSCs) on the healing
of a collagenase-induced bilateral tendinopathy lesions in
an equine ﬂexor digitorum superﬁcialis injury model. Both
MSC and AdIGF-MSC injections resulted in signiﬁcantly
improved tendon histological scores [37].
Tissue engineering techniques using novel scaﬀold mate-
rials oﬀer potential alternatives for managing irreparable
rotator cuﬀ tears. A chitosan-based hyaluronan hybrid scaf-
fold, with seeded ﬁbroblasts to repair infraspinatus tendons
defects produced in rabbits, demonstrated an enhanced
type I collagen production and a signiﬁcant improvement
in tensile strength and tangent modulus from 4 to 12
weeks postoperatively [38]. In vivo, the eﬀect of auto-
crosslinked HA gel on adhesions and healing of injured
and surgically repaired rabbit digital ﬂexor tendons was
studied, demonstrating a signiﬁcantly faster increase in
breaking strength with an accelerated tissue repair response
after injury, but unaﬀected adhesions formation [39]. In
rabbits, MSCs expanded in culture, suspended in type
I collagen gel, and implanted into a surgically induced
defect in the donor’s right patellar tendon demonstrated
signiﬁcant increases in maximum stress, modulus, and strain
energy density [40]. Changes in nuclear morphology of
the MSCs in response to physical constraints provided by
the contracted collagen ﬁbrils may trigger diﬀerentiation
pathways toward the ﬁbroblastic lineage and inﬂuence the
cell synthetic activity [41]. Controlling the contraction and
organization of the cells and matrix will be critical to
successfully produce tissue-engineered grafts. Seeded col-
l a g e ng e l sw i t hr a b b i tb o n e - m a r r o w - d e r i v e dM S C sa n d
contracted onto sutures were implanted into full thickness,
full length, central defects in the patellar tendons of the
animals [40]. Repair tissues containing the MSC-collagen
composites showed signiﬁcantly higher maximum stresses
and moduli than natural repair tissues at 12 and 26 weeks
post surgery [40]. Autogenous tissue-engineered constructs
were fabricated in culture between posts in the wells of
silicone dishes [42]. Constructs were implanted in bilateral
2-cm-long gap defects in the rabbit’s lateral Achilles tendon.
At 12 weeks after surgery, no signiﬁcant improvement was
observed in any structural or mechanical properties or in
histological appearance compared with control. The same
authors tried also to determine how a tensile stimulus aﬀects
the gene expression of stem cell-collagen sponge constructs
used to repair rabbit central patellar tendon defects [42].
MSCs were introduced into a gel-sponge composite showing
cellular alignment comparable with that of normal tendon
[43]. Cao et al. [4] tested the feasibility of engineering
tendon tissues with autologous tenocytes to bridge a tendon
defect in either a tendon sheath open model or a partial
open model in the hen. FDP defects were bridged either
with a cell-scaﬀold construct in the experimental group
or with scaﬀold material alone in the control group. At
14 weeks, the engineered tendons resembled the natural
tendons grossly in both colour and texture and displayed
a typical tendon structure hardly distinguishable from that
of normal tendons. The same authors also explored the
feasibility of in vitro tendon engineering using the same type
of cells and scaﬀold material [44]. Unwoven polyglycolic
acid (PGA) ﬁbers were arranged into a cord-like construct
and ﬁxed on a U-shape spring, and tenocytes were then
seeded on PGA ﬁbers to generate a cell-PGA construct.
The results showed that tendon tissue could be generated
during in vitro culture. In addition, the tissue structure
and mechanical property became more mature and stronger
with the increase of culture time. Alginate-based chitosan
hybrid polymer ﬁbers showed much improved adhesion
capacity with tenocytes compared with alginate polymer
ﬁber [45]. The rAAV-Gdf5 vector signiﬁcantly accelerates
wound healing in an in vitro ﬁbroblast scratch model and,
when loaded onto freeze-dried ﬂexor digitorum longus
tendon allografts, improves the metatarsophalangeal joint
ﬂexion to a signiﬁcantly greater extent than the rAAVlacZ
controls do [46]. In an experimental study on rabbits, a
sharp complete midsubstance transection of the Achilles
tendon was immediately repaired using a modiﬁed Kessler’s
suture and a running epitendinous suture. Both limbs were
used, and each side was randomized to receive either bone-
marrow-derived MSCs in a ﬁbrin carrier or ﬁbrin carrier
alone (control). At 6 and 12 weeks, there were no diﬀer-
ences between the groups with regard to morphometric
nuclear parameters. Biomechanical testing showed improved
modulus in the treatment group as compared with the
control group at 3 weeks, but not at subsequent time periods
[47].
Costa et al. [48] tried to optimize tenocyte prolifera-
tion in three tendon cell populations using growth factor
supplementation. They isolated cells of the synovial sheath,
epitenon, and endotenon from rabbit FDP tendons and
maintained them in culture. For all three tendon cell popu-
lations, proliferation at 72 hours was greater in the presence
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addition, a synergistic eﬀect was observed. The combina-
tion of growth factors resulted in greater proliferation as
compared with maximal doses of individual growth fac-
tors. Synthetic oligo[poly(ethylene glycol)fumarate]-(OPF-
) based biomaterials were tested as a mean to deliver
ﬁbroblasts to promote regeneration of central/partial defects
in tendons and ligaments. To further modulate the swelling
anddegradativecharacteristicsofOPF-basedhydrogels,OPF
crosslinking via a radically initiated, mixedmode reaction
involving poly(ethylene glycol) (PEG) diacrylate (PEG-
DA) and PEG-dithiol was investigated. After encapsulation,
tendon/ligament ﬁbroblasts remained largely viable over
8 days of static culture. Although the presence of PEG-
dithiol did not signiﬁcantly aﬀect cellularity or collagen
production within the constructs over this time period,
image analysis revealed that the 20% PEG-dithiol gels did
appear to promote cell clustering, with greater values for
aggregate area observed by day [49].
The use of a PEG-DA hydrogel incorporated with hy-
droxyapatite (HA) and the cell-adhesion peptide RGD (Arg-
Gly-Asp) was tested as a material for determining an in vitro
tissue interface to engineer intact ligaments. Incorporation
of HA into PEG hydrogels reduced the swelling ratio but
increased mechanical strength and stiﬀness of the hydrogels.
Further, HA addition increased the capacity for cell growth
and interface formation. RGD incorporation increased the
swelling ratio but decreased mechanical strength and stiﬀ-
ness of the material [50].
A novel fabrication system for photopatterning and as-
sembling cell-laden OPF:PEG-DA hydrogels with high spa-
tial ﬁdelity and thickness using a controlled, inert nitrogen
environment was described [51]. Cross-linking was per-
formed using Irgacure-2959 photoinitiator and 365nm light
(7mW/cm2)toformgelsrangingfrom0.9to3mminwidth.
Employing an N2 environment increased gel thickness up
to 240%, generating gels greater than 1mm thick prior to
swelling. This technique was further applied for spatially
controlledpatterningofprimarytendon/ligamentﬁbroblasts
andmarrowstromalcellsinasingle1.5-mm-thicklaminated
hydrogel construct. Cells encapsulated using this technique
maintained viability over 14 days in culture [51].
5. Discussion
The emerging ﬁeld of tissue engineering holds the promise
to use materials in tendon injury repair, namely, artiﬁcial
polymers, biodegradable ﬁlms, and biomaterials derived
from animals or human (ECM devices) [7]. The most
innovative strategy in tendon injury repair is the use of ECM
matrices [52–62]. In contrast to traditional polymeric and
metallic orthopaedic devices, intended to restore mechanical
function and remain unchanged for the life of the patient
[63–76], ECMs are temporary scaﬀold aimed to enhance and
accelerate the biology of tissue repair [77, 78]. They undergo
host cell inﬁltration and constructive tissue remodelling
at variable rates [79]. Potential advantages of the use of
ECM grafts include the capability to decrease the in vivo
mechanical forces on the tendon repair during postoperative
healing, to prevent repair gap formation or failure, to allow
host cell inﬁltration and ideally even enhance the biology
healing, and to be replaced by organized host tissue over
time [80–87]. Additional research studies are required to
verify these issues. The ideal scaﬀold should induce host-
tissue ingrowth and tendon regeneration during the process
of degradation, which varies dramatically among the com-
mercially available scaﬀolds [88]. The capability of inducing
host-tissue ingrowth is superior when using biological
scaﬀolds, even though this process appears uncontrolled and
nonspeciﬁc [89]. The interaction between scaﬀold surface
and host cells is a key aspect of the use of scaﬀolds for
tendonreconstruction.Intheﬁrstphaseofcellularingrowth,
multiple attachment points are established by the cells
through the interaction between transmembrane proteins
and proteins at the scaﬀold surface [6], later strengthened
by accumulating integrin receptors, eventually forming a
focal adhesion which acts as a connection between the actin
cytoskeleton of the cell and the surface [6]. The cell prolif-
eration cycle and cell migration start after the formation of
focal adhesions and spreading of cells on the surface [6]. Cell
attachment, proliferation, and migration is facilitated by the
porosity of scaﬀolds [90]. The surface of biological scaﬀolds
is mostly composed of natural type I collagen protein, which
determines a higher aﬃnity to host cells and, therefore,
promotes cellular adhesion, proliferation, migration, and
tissue induction [6].
On the other hand, the surfaces of synthetic scaﬀold are
composed of macromolecules lacking a well-deﬁned struc-
ture that allows host cell to produce a strong binding point
and start growing [6].
Even though biological scaﬀolds are becoming more
popular, clinical well-conducted human studies are lacking,
and little data describing the complications or adverse events
associated with the use of these products are available. ECMs
fabricating in parallel with other materials may increase their
mechanical properties, such as natural ECMs seeded with
bone marrow stem cells or tenocytes [91–101]. However,
clinical evidence in this ﬁeld is scanty. Major concern about
bothbiologicalandsyntheticscaﬀoldsisthebiocompatibility
and the inﬂammatory response associated with foreign body
rejection [6]. To decrease the bioburden and the risk of
inﬂammatoryorforeignbodyreactions,alltissues,regardless
of their origin, are extensively puriﬁed to remove proteins,
cells, and lipids. Some graft options have been artiﬁcially
crosslinked to decrease antigenicity, by decreasing their sen-
sitivity to collagenases [1, 102–113]. Although rare, aseptic,
nonspeciﬁc inﬂammatory reactions and foreign body-like
r e a c t i o n sh a v eb e e nr e p o r t e dw i t hc e r t a i nx e n o g r a f t s[ 7,
8, 12, 114, 115]. Aseptic reactions were reported in 16–
22% [115] of implantations, always with negative aspirates
and cultures, destroyed xenografts, and histopathological
evidence of inﬂamed granulation tissue with abundant
neutrophils, but no foreign body reaction, as documented
by the absence of organisms, crystals, or giant cells [8, 115,
116]. Valentin et al. [88] examined the host-tissue morpho-
logic response to ﬁve commercially available extracellular
matrix-derived biological scaﬀolds (GraftJacket, Restore,
CuﬀPatch, TissueMend, Permacol) used for orthopaedic
soft-tissue repair in a rodent model. Each device elicited6 Stem Cells International
a distinct morphologic response that diﬀered with respect
to cellularity, vascularity, the presence of multinucleated
giant cells, and organization of the remodelled tissue [117–
129] .M o r er a p i d l yd e g r a d e dd e v i c e ss u c ha sR e s t o r ea n d
autologous tissue showed the greatest amount of cellular
inﬁltration, especially at the early time points [78, 130–
146]. Devices that degraded slowly, such as CuﬀPatch, Tis-
sueMend, and Permacol, were associated with the presence
of foreign-body giant cells, chronic inﬂammation, and/or
the accumulation of dense, poorly organized ﬁbrous tissue
[2, 147–160]. Depending on the product, processing may
involve acellularization treatment, chemical cross-linking,
lamination of multiple layers or lyophilization [161]. These
biomaterials have incomplete acellularization [12, 77], and
the clinical implications are still not clear. Acellularization
treatmentaims to reduce antigenicity, by disrupting cells and
removing water-soluble cellular proteins. Acellularization
may also enhance host cell inﬁltration with phenotypically
appropriate cells [162] and possibly prevent transmission
of infectious genomic vectors [163]. Further biochemical
and immunologic investigations are required to establish
whether and how much acellularization treatment increases
thesafetyandeﬃcacyoftheseimplants.Theuseof biological
scaﬀolds manufactured from human or animal tissue carries
also the risk of disease transmission, which, even though
not reported to date, remains a theoretical concern [164–
176]. Obviously, there is no risk of disease transmission with
the use of synthetic scaﬀolds [6]. One of the advantages of
biomaterials is that exogenous growth factors, gene therapy
approaches, or cell delivery can be used together with
these biomaterials. Several chemical cross-linking agents
(i.e., glutaraldehyde, polyepoxy compound, carbodiimide,
genipin, isocyanate, and proanthocyanidin) have been used
to stabilize the collagenstructure of the scaﬀold, maintaining
the mechanical properties [176–189]. Clinical studies have
not conﬁrmed the expected beneﬁcial eﬀect of chemical
cross-linking scaﬀolds. Further investigations are warranted
to establish the in vivo beneﬁt of chemical cross-linking in
biocompatibility and mechanical properties on the scaﬀolds.
As Chen et al. [6] proposed, another reason of concern is
that available scaﬀolds are produced to mimic the tendon
or ligament extracellular microenvironment to stimulate
cell proliferation and tissue ingrowth, largely ignoring the
healing process at the enthesis. The repair procedure often
involvesreconstructionofthejunction,andfailureofsurgery
is frequently caused by osteolysis and scaﬀold pullout.
Further investigations are required to better understand how
to promote the healing of bone-tendon junction.
6. Conclusion
Tendon disorders are frequent and cause signiﬁcant morbid-
ity both in sports and workplace [144, 177, 190]. Several
c o n s e r v a t i v ea n ds u r g i c a lp r o c e d u r e sa r ea v a i l a b l ef o rt e n -
don healing, but one of the major problems encountered
when dealing with tendinopathies is that etiology is largely
unknown [65, 86, 94, 96, 173].
Preliminary studies support the idea that scaﬀolds can
provide an alternative for tendon augmentation with an
enormous therapeutic potential. However, available data are
lacking to allow deﬁnitive conclusion on the use of scaﬀolds
for tendon augmentation. Additionally, the prevalence of
postoperative complications encountered with their use
varies within the diﬀerent studies. Further investigations
are required to evaluate the role of scaﬀolds in the clinical
practice.
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